Rchr
J-GLOBAL ID:200901036657906185   Update date: Nov. 23, 2024

Suzuki Toyofumi

スズキ トヨフミ | Suzuki Toyofumi
Affiliation and department:
Job title: Professor
Research field  (4): Clinical pharmacy ,  Clinical pharmacy ,  Clinical pharmacy ,  Clinical pharmacy
Research keywords  (13): Drug Delivery to the Brain ,  Blood-Brain Barrier Transport ,  Nose-to-Brain ,  Intranasal formulations ,  Nasal spray formulation / Nasal powder formulation ,  経鼻吸収 ,  transdermal therapeutic system ,  Drug Absorption ,  Cerebral Ischemia ,  cerebral ischemic reperfusion injury ,  半固形製剤 ,  Syrup for Infants ,  Orally disintegrating tablet
Research theme for competitive and other funds  (21):
  • 2019 - 2021 鼻から脳への薬物移行経路を介した経鼻投与製剤の基盤技術の開発と中枢疾患治療戦略
  • 2017 - 2020 脳神経系希少疾患治療を目指した経鼻投与による脳内バイオ医薬デリバリー戦略の構築
  • 2018 - 2019 薬物封入ナノキャリアが虚血性脳梗塞急性期における脳神経保護効果に及ぼす影響
  • 2018 - 2018 脳松果体から分泌される中分子ペプチドホルモン・メラトニンの鼻から脳への薬物送達とその移行経路の解明
  • 2017 - 2018 虚血性脳梗塞に対する薬物の経鼻投与経路の有用性
Show all
Papers (129):
  • Toyofumi Suzuki. Drug delivery to the brain: Recent advances. 2024. 84. 3. 128-133
  • Ayumi Kashiwada, Narumi Taoka, Yukiha Chijimi, Keiko Noguchi, Karin Shigematsu, Motofumi Miura, Toyofumi Suzuki. Weakly acidic pH-responsive liposomal content release induced by histidine-modified agents. Organic & Biomolecular Chemistry. 2024. 22. 2844-2850
  • Naoto Suzuki, Hiroaki Tanigawa, Taiki Nagatomo, Hiroko Miyagishi, Takanori Kanazawa, Toyofumi Suzuki, Yasuhiro Kosuge. Utility of a novel micro-spraying device for intranasal administration of drug solutions to mice. Pharmaceutics. 2023. 15. 11. 2553
  • Komugi Tsuruta, Takato Shidara, Hiroko Miyagishi, Hiroshi Nango, Yoshihiko Nakatani, Naoto Suzuki, Taku Amano, Toyofumi Suzuki, Yasuhiro Kosuge. Anti-inflammatory effects of Miyako Bidens Pilosa in a mouse model of amyotrophic lateral sclerosis and lipopolysaccharide-stimulated BV-2 microglia. International Journal of Molecular Sciences. 2023. 24. 18. 13698
  • Muramori So, Yasuhiro Tsuji, Toyofumi Suzuki. Efficacy of zinc acetate hydrate for hypozincemia in the elderly is influenced by the initial accumulated exposure dose after taking zinc acetate hydrate. Pharmazie. 2023. 78. 9-10. 201-206
more...
MISC (142):
more...
Patents (13):
  • Pharmaceutical composition for external use (Canada)
  • Pharmaceutical composition for external use (South Korea)
  • Matrix-type patch preparation and method for producing same (Taiwan)
  • Externally-applied medicinal composition (China)
  • Pharmaceutical composition for external use (USA)
more...
Books (10):
  • 新規モダリティ医薬品のための新しいDDS技術と製剤化
    Technical Information Institute Co., Ltd. 2023 ISBN:9784861049361
  • 「薬物療法の質を大きく変える剤形・投与経路Q&A」月刊薬事2022年4月臨時増刊号(Vol. 64 No. 6)
    (株)じほう 2022
  • Clinical Pharmaceutics <5rd Edition>
    NANKODO 2022 ISBN:9784524403936
  • できる薬剤師とよばれるために-上手に使いたい薬学ナレッジ101
    (株)じほう 2021 ISBN:9784840754019
  • 医薬品におけるDDS技術開発と製剤への応用
    Johokiko Co., Ltd. 2021 ISBN:9784865022278
more...
Lectures and oral presentations  (657):
  • N2Bを介したイヌリンの脳移行に及ぼすイオン液体の影響と多孔性シリカへの封入による製剤化[P2-36]
    (日本薬剤学会第39年会(神戸) 2024)
  • フェニトインのコアモルファス化が経鼻投与時の脳移行性に及ぼす影響[P2-35]
    (日本薬剤学会第39年会(神戸) 2024)
  • Effect of coamorphous consisted of phenytoin on solubility in nasal mucus and brain transport after intranasal administration[31-313-pm13]
    (The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama) 2024)
  • Therapeutic effects of N-acetyl-L-cysteine by intranasal administration combined with cell-penetrating peptide-modified polymer micelles in mouse models of neuropathic pain[31P-am268]
    (The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama) 2024)
  • Neuroprotective effects in the brain by intranasal administration of 2-ethyl-6-methyl-3-hydroxypyridine succinate[P30-pm407S]
    (The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama) 2024)
more...
Professional career (1):
  • 博士(薬学) (日本大学)
Work history (6):
  • 2016/04 - 現在 School of Pharmacy, Nihon University Laboratory of Pharmaceustics Professor
  • 2011/04 - 2016/03 School of Pharmacy, Nihon University Laboratory of Pharmaceutics Associate Professor
  • 2004/04 - 2011/03 School of Pharmacy, Nihon University Laboratory of Pharmaceutics Lecturer
  • 2003/09 - 2004/03 School of Pharmacy, Nihon University Laboratory of Pharmaceutics Assistant Professor
  • 2002/08 - 2003/09 University of California at Los Angeles (UCLA), School of Medicine Department of Medicine/Endocrinology (Prof. Pardridge) Postgraduate Scientist (Visiting Researcher)
Show all
Committee career (16):
  • 2024/04 - 現在 The Pharmaceutical Society of Japan Section Editor-in-Chief, The Editorial Committee of the Pharmaceutical Society of Japan
  • 2019/02 - 現在 The Pharmaceutical Society of Japan 代議員
  • 2018/04 - 現在 The Academy of Pharmaceutical Science and Technology, Japan (APSTJ) 代議員
  • 2023/10 - 2024/03 The Pharmaceutical Society of Japan The Pharmaceutical Society of Japan
  • 2023/04 - 2024/03 Ministry of Health, Labour and Welfare The 109th Pharmacist National Examination, Pharmacy Examination Board
Show all
Awards (6):
  • 2021/09 - Japan Oil Chemists' Society The 20th Japan Oil Chemists' Society, Oleo Science Transport Mechanism in the Nose-to-Brain Drug Delivery and Role of Nanosystems
  • 2017/10 - The 50th
  • 2010/10 - 2010
  • 2006/07 - The APSTJ Global Education Seminar The APSTJ Global Education Seminar Presentation Award 2006 Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology
  • 2005/06 - The Journal of Nuclear Medicine Editor's Selection Award 2004 (Outstanding Basic Science Investigation) from The Journal of Nuclear Medicine
Show all
Association Membership(s) (5):
Academy of Pharmaceutical Science and Tschnology of Japan (APSTJ) ,  The Japanese Society for the Study of Xenobiotics (JSSX) ,  The Pharmacutical Society of Japan#9305569 ,  日本DDS学会 ,  The Japanese Society of Clinical Pharmacology and Therapeutics
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page